%0 Journal Article %A Alonso-Ojembarrena, Almudena %A Oulego‑Erróz, Ignacio %T Intravitreal Bevacizumab for Retinopathy of Prematurity: Another Hit to the Immature Lung? %D 2022 %@ 0012-3692 %U http://hdl.handle.net/10498/29411 %X Laser photocoagulation has been the standard of treatment of ROP for many years. However, since its introduction in 2007, the use of intravitreal injection of anti-VEGF agents has been incorporated to ROP management. Several trials have shown that anti-VEGF drugs (bevacizumab, ranibizumab) may be superior to laser photocoagulation for type I ROP (zone I [any stage with plus disease] or zone I-stage 3 without plus disease) %K Retinopathy of prematurity (ROP) %K Bevacizumab %K Retinopathy of Prematurity %~ Universidad de Cádiz